Putting the Bio in Canadian Biomanufacturing
By Eduardo Longoria “One of the things to remember is Canada no longer has any domestic production capacity for vaccines. We used to have it […]
By Eduardo Longoria “One of the things to remember is Canada no longer has any domestic production capacity for vaccines. We used to have it […]
By Eduardo Longoria An article published recently in the journal Nature reported findings on how the gut microbiota influences the development and maintenance of the mammalian immune […]
By Eduardo Longoria Boston-based Ginkgo Bioworks has received a $1.1 billion investment from the US government’s International Development Finance Corp (DFC) for COVID-19 testing and […]
By Eduardo Longoria On November 12th, California-based Twist Biosciences, Illumina, Microsoft, and Western Digital announced the launching of a joint effort with 11 other companies to advance the field of DNA data […]
By Eduardo Longoria Genome editing is the process by which researchers make targeted changes to an organism’s DNA. While there are various technologies for genome editing, the […]
By Eduardo Longoria On September 29th, Dewpoint Therapeutics, the biomolecular condensates company, announced raising US$ 77 million in a Series B round led by ARCH Venture Partners. The round […]
Copyright © 2024 | WordPress Theme by MH Themes